Journals / Turkish journal of nephrology (Online) / 2019 / Cilt: 28 - Sayı: 1

Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis Patients

Pages
17–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, we could not find any association between the urine angiotensinogen-to-creatinine ratioand blood pressure values.Conclusion: Local RAS activation in the kidney reflected by urinary angiotensinogen is associated with RRF and proteinuriain patients undergoing PD; however, high blood pressure was not correlated with urinary angiotensinogen levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Several studies have shown that local renin–angiotensin system (RAS) activity in the kidneys may play a role inthe pathogenesis of hypertension and kidney damage in patients with chronic kidney disease.
📊
Key Findings & Data:They were dividedinto the hypertensive (n=30) and non-hypertensive (n=20) groups.
💡
Conclusion & Impact:However, we could not find any association between the urine angiotensinogen-to-creatinine ratioand blood pressure values.Conclusion: Local RAS activation in the kidney reflected by urinary angiotensinogen is associated with RRF and proteinuriain patients undergoing PD; however, high blood pressure was not correlated with urinary angiotensinogen levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Several studies have shown that local renin–angiotensin system (RAS) activity in the kidneys may play a role inthe pathogenesis of hypertension and kidney damage in patients with chronic kidney disease. In this study, we aimed toinvestigate the effect of local RAS activity on hypertension and residual renal function (RRF) in patients undergoing peritoneal dialysis (PD).Materials and Methods: Fifty patients with residual urine undergoing PD were included in the study. They were dividedinto the hypertensive (n=30) and non-hypertensive (n=20) groups. The urine angiotensinogen-to-creatinine ratio, which isan indicator of local RAS activity, was compared between the two groups. Factors affecting this ratio were also investigated.Results: There was no significant difference in the mean urine angiotensinogen-to-creatinine ratios between the twogroups. A correlation analysis revealed that the urine angiotensinogen-to-creatinine ratio had a significant negative correlation with RRF determined by 24-hour creatinine excretion (r=−0.391, p=0.005). There was a positive correlation betweenthe urine angiotensinogen-to-creatinine ratio with proteinuria (r=0.289, p=0.04) and negative correlation with serum albumin (r=−0.280, p=0.049). However, we could not find any association between the urine angiotensinogen-to-creatinine ratioand blood pressure values.Conclusion: Local RAS activation in the kidney reflected by urinary angiotensinogen is associated with RRF and proteinuriain patients undergoing PD; however, high blood pressure was not correlated with urinary angiotensinogen levels.

🔖

Cite This Article

YILDIRIM, T., YILMAZ, R., AZAK, A., ALTINDAL, M., TÜRKMEN, E., ARICI, M., DURANAY, M., ERDEM, Y., ALTUN, B. (2019). Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online), Cilt: 28 - Sayı: 1, 17–23. https://ajindex.com/articles/374905

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Lameire N, Bernaert P, Lambert MC, Vijt D. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis. Kidney Int Suppl 1994; 48: S31-S38
  2. Rocco MV, Flanigan MJ, Beaver S, Frederick P, Gentile DE, McClellan WM, et al. Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group. Am J Kidney Dis 1997; 30: 165-73. [CrossRef] 3. Ortega LM, Materson BJ. Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis and treatment. J Am Soc Hypertens 2001; 5: 128-36. [CrossRef] 4. Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, Sturani A, Quarello F, et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536-40. [CrossRef] 5. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16: 2207-13. [CrossRef] 6. Weir MR, Dzau VJ. The renin angiotensin aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12: 205S-213S. [CrossRef] 7. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, et al. Elements of a paracrine tubular renin angiotensin system along the entire nephron. Hypertension 1999; 34: 1265-74. [CrossRef] 8. Lantelme P, Rohrwasser A, Gociman B, Hillas E, Cheng T, Petty G, et al. Effects of dietary sodium and genetic background on angiotensinogen and renin in mouse. Hypertension 2002; 39: 1007-14. [CrossRef] 9. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003; 41: 42-9. [CrossRef] 10. Aybal Kutlugun A, Altun B, Buyukasik Y, Aki T, Turkmen E, et al. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? Transpl Int 2012; 25: 13-8.[CrossRef] 11. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-87 [CrossRef] 12. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure meas